Literature DB >> 7484277

Characterization of MCSF-induced proliferation and subsequent osteoclast formation in murine marrow culture.

D M Biskobing1, X Fan, J Rubin.   

Abstract

To clarify events involved in 1,25(OH)2D3-stimulated osteoclast-like cell (OCLC) formation in primary murine marrow culture, we have characterized kinetics of precursor proliferation and fusion and their dependence on macrophage colony-stimulating factor (MCSF). 3H-thymidine nuclear incorporation in tartrate-resistant acid phosphatase positive multinucleated cells (TRAP+ MNCs) was assessed: 3H-thymidine incorporation was greatest when tracer was added during day 4 or 5, with labeled nuclei in 81% (day 4) and 90% (day 5) of the TRAP+ MNCs counted at the end of day 7. The percentage of total nuclei labeled was highest when 3H-thymidine was dosed on day 4 (58%), decreasing to 2% by day 7. Final TRAP+ MNC numbers were depleted by 80% when treated for 24 h with hydroxyurea on either day 3 or 4; this inhibition dropped to 57% and 12% when hydroxyurea was pulsed during days 5 or 6, respectively. The absence of 1,25(OH)2D3 during days 1-4 caused 70% attenuation of TRAP+ MNC formation; however, exposure to 3H-thymidine during day 4 in this experiment resulted in subsequent labeling of 81% of the TRAP+ MNCs formed, indicating that precursor proliferation occurred in the absence of 1,25(OH)2D3. To demonstrate that proliferation required MCSF, cultures were exposed to a monoclonal anti-MCSF antibody during days 3, 4, 5, 6, or 7. Inhibition of TRAP+ MNC formation was 85% when antibody was added during day 3. Antibody treatment after day 5 had little effect on the OCLC number. Fusion of precursors showed steady progression with OCLCs containing 4.8 +/- 0.3 nuclei at the end of day 4, 8.3 +/- 0.5 nuclei after day 5, 12.0 +/- 1.3 after day 6, and 13.7 +/- 1.5 at the end of day 7. This steady accretion of nuclei was unaffected by doses of MCSF antibody which blocked proliferation. In conclusion, we have shown that OCLCs arise from an MCSF-dependent expansion of the precursor pool occurring during days 3 and 4. Fusion of these precursors, which begins as proliferation diminishes, is able to progress in the presence of anti-MCSF antibody. These results should help refine the analysis of factors affecting proliferation and fusion of osteoclasts in murine marrow culture.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7484277     DOI: 10.1002/jbmr.5650100706

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  18 in total

1.  Both cell-surface and secreted CSF-1 expressed by tumor cells metastatic to bone can contribute to osteoclast activation.

Authors:  Kader Yagiz; Susan R Rittling
Journal:  Exp Cell Res       Date:  2009-05-08       Impact factor: 3.905

2.  A marine fungus-derived nitrobenzoyl sesquiterpenoid suppresses receptor activator of NF-κB ligand-induced osteoclastogenesis and inflammatory bone destruction.

Authors:  Yanhui Tan; Wende Deng; Yueyang Zhang; Minhong Ke; Binhua Zou; Xiaowei Luo; Jianbin Su; Yiyuan Wang; Jialan Xu; Kutty Selva Nandakumar; Yonghong Liu; Xuefeng Zhou; Xiaojuan Li
Journal:  Br J Pharmacol       Date:  2020-08-11       Impact factor: 8.739

3.  Alpha9beta1: a novel osteoclast integrin that regulates osteoclast formation and function.

Authors:  Hongwei Rao; Ganwei Lu; Hiroshi Kajiya; Veronica Garcia-Palacios; Noriyoshi Kurihara; Judy Anderson; Ken Patrene; Dean Sheppard; Harry C Blair; Jolene J Windle; Sun Jin Choi; G David Roodman
Journal:  J Bone Miner Res       Date:  2006-10       Impact factor: 6.741

4.  The effects of P2X7 receptor antagonists on the formation and function of human osteoclasts in vitro.

Authors:  Ankita Agrawal; Katherine A Buckley; Keith Bowers; Mark Furber; James A Gallagher; Alison Gartland
Journal:  Purinergic Signal       Date:  2010-04-21       Impact factor: 3.765

Review 5.  Regulation of Embryonic and Postnatal Development by the CSF-1 Receptor.

Authors:  Violeta Chitu; E Richard Stanley
Journal:  Curr Top Dev Biol       Date:  2016-12-01       Impact factor: 4.897

Review 6.  Impact of inflammation on the osteoblast in rheumatic diseases.

Authors:  Rebecca Baum; Ellen M Gravallese
Journal:  Curr Osteoporos Rep       Date:  2014-03       Impact factor: 5.096

7.  Stage-dependent suppression of the formation of dentin-resorbing multinuclear cells with migration inhibitory factor in vitro.

Authors:  Takashi Kikuiri; Yoshitaka Yoshimura; Futoshi Tabata; Tomokazu Hasegawa; Jun Nishihira; Tetsuo Shirakawa
Journal:  Exp Ther Med       Date:  2011-10-07       Impact factor: 2.447

8.  Cloning and identification of human Sca as a novel inhibitor of osteoclast formation and bone resorption.

Authors:  S J Choi; R D Devlin; C Menaa; H Chung; G D Roodman; S V Reddy
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

9.  Osteoporosis regulation by salubrinal through eIF2α mediated differentiation of osteoclast and osteoblast.

Authors:  Long He; Junwon Lee; Jae Hyuk Jang; Krisada Sakchaisri; Joonsung Hwang; Hyun Joo Cha-Molstad; Kyung A Kim; In Ja Ryoo; Hee Gu Lee; Sun Ok Kim; Nak Kyun Soung; Kyung Sang Lee; Yong Tae Kwon; Raymond Leo Erikson; Jong Seog Ahn; Bo Yeon Kim
Journal:  Cell Signal       Date:  2012-11-23       Impact factor: 4.315

10.  RO4929097 regulates RANKL-induced osteoclast formation and LPS-mediated bone resorption.

Authors:  Tao Huang; Congyun Zhao; Yi Zhao; Yuan Zhou; Lei Wang; Donghua Hang
Journal:  Aging (Albany NY)       Date:  2021-05-02       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.